Strides Pharma Global, Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg and 400 mg from the Food and Drug Administration. The product is the generic of Upjohn’s Celebrex. The ...

Reported Consolidated quarterly numbers for Strides Pharma Science are: Net Sales at Rs 1,194.65 crore in December 2025 up ...

Reported Standalone quarterly numbers for Strides Pharma Science are: Net Sales at Rs 553.63 crore in December 2025 up 0.49% ...

Strides Pharma Science share price jumped up to 12% in Friday's intra-day trade after the company reported strong Q3FY26 ...

Strides Pharma Science announced that Strides Pharma Inc. (SPI), a step-down wholly owned subsidiary of the Company in the USA, has received the USFDA Inspection Closure Report (Establishment ...

Strides Pharma Science Ltd on Thursday said its arm Strides Pharma Inc (SPI) has received establishment inspection report from the US health regulator for its formulations unit at Chestnut Ridge in ...

Partnership strengthens Strides' pipeline of nasal spray products across diverse therapeutic areas Kenox to provide formulation and development expertise in Orally Inhaled and Nasal Drug Products ...

Strides Pharma was hit with a patent infringement lawsuit on Oct. 17 in New Jersey District Court. The action, brought by Robinson Miller LLC on behalf of Braintree Laboratories, asserts a single ...

Strides Pharma Science Limited announced that its step-down wholly owned subsidiary, Strides Pharma Inc., has received the ...

The average one-year price target for Strides Pharma Science (NSEI:STAR) has been revised to ₹ 1,244.40 / share. This is a decrease of 19.21% from the prior estimate of ₹ 1,540.20 dated September 27, ...

Announcement under Regulation 30 (LODR)-Press Release / Media Release - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, ...